(Q34453066)

2 August 2017

0 references

1 reference

title

Screening for the early detection of disease, the need for evidence (English)

1 reference

2 August 2017

Matthew J McQueen

1

1 reference

2 August 2017

publication date

1 January 2002

1 reference

2 August 2017

1 reference

2 August 2017

volume

315

1 reference

2 August 2017

issue

1-2

1 reference

2 August 2017

page(s)

5-15

1 reference

AN EVALUATION OF THE PERIODIC HEALTH EXAMINATION. THE FINDINGS IN 350 EXAMINEES WHO DIED.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Some pitfalls in the evaluation of screening programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Psychological consequences of screening mammography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Screening for Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Effects of labelling on income, work and social function among hypertensive employees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Increased absenteeism from work after detection and labeling of hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Screening could seriously damage your health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Maternal serum screening for Down's syndrome in early pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Effect of screening algorithm, parameter values and median smoothing on patient-specific risk estimates for Down's syndrome screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Prenatal Screening for Down's syndrome: Authors' reply.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Integrated screening for Down's syndrome based on tests performed during the first and second trimesters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Neonatal group B streptococcal disease--screening and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Rapid detection of group B streptococci in pregnant women at delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Evidence-based medicine: its application to laboratory medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Management of diabetes mellitus from a public health perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

The normal, and the perils of the sylleptic argument

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

The Value of Routine Preoperative Medical Testing before Cataract Surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Biochemical profiles for hospital patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Should we screen for gestational diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Screening for gestational diabetes mellitus. A simple test may make it easier to study whether screening is worthwhile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

Number needed to screen: development of a statistic for disease screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900709-4

10.1016/S0009-8981(01)00709-4

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference